7,289 reports of this reaction
3.5% of all SACUBITRIL AND VALSARTAN reports
#7 most reported adverse reaction
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #7 most commonly reported adverse reaction for SACUBITRIL AND VALSARTAN, manufactured by Novartis Pharmaceuticals Corporation. There are 7,289 FDA adverse event reports linking SACUBITRIL AND VALSARTAN to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 3.5% of all 209,561 adverse event reports for this drug.
SACUBITRIL AND VALSARTAN has an overall safety score of 85 out of 100. Patients taking SACUBITRIL AND VALSARTAN who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is moderately reported among SACUBITRIL AND VALSARTAN users, representing a notable but not dominant share of adverse events.
In addition to wrong technique in product usage process, the following adverse reactions have been reported for SACUBITRIL AND VALSARTAN:
The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 7,289 FDA reports for SACUBITRIL AND VALSARTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 3.5% of all adverse event reports for SACUBITRIL AND VALSARTAN, making it a notable side effect.
If you experience wrong technique in product usage process while taking SACUBITRIL AND VALSARTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.